Neuron loss in transgenic mouse models of Alzheimer's disease

International Journal of Alzheimer's Disease

Volumn , Issue , 2010, Pages

  Wirths, Oliver ^a   Bayer, Thomas A ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; BEHAVIOR DISORDER; GENE MUTATION; IN VIVO STUDY; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW;

EID: 77956815064     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2010/723782     Document Type: Review

References (47)

1. Hardy J., Allsop D., Amyloid deposition as the central event in the aetiology of Alzheimer's disease Trends in Pharmacological Sciences 1991 12 10 383 388
2. Braak H., Braak E., Neuropathological stageing of Alzheimer-related changes Acta Neuropathologica 1991 82 4 239 259
3. Gouras G. K., Tsai J., Naslund J., Vincent B., Edgar M., Checler F., Greenfield J. P., Haroutunian V., Buxbaum J. D., Xu H., Greengard P., Relkin N. R., Intraneuronal A 42 accumulation in human brain American Journal of Pathology 2000 156 1 15 20
4. Wirths O., Multhaup G., Bayer T. A., A modified -amyloid hypothesis: intraneuronal accumulation of the -amyloid peptidethe first step of a fatal cascade Journal of Neurochemistry 2004 91 3 513 520
5. Duyckaerts C., Potier M.-C., Delatour B., Alzheimer disease models and human neuropathology: similarities and differences Acta Neuropathologica 2008 115 1 5 38
6. Games D., Buttini M., Kobayashi D., Schenk D., Seubert P., Mice as models: transgenic approaches and Alzheimer's disease Journal of Alzheimer's Disease 2006 9 supplement 3 133 149
7. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagoplan S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., Alzheimer-type neuropathology in transgenic mice overexpressing V717F -amyloid precursor protein Nature 1995 373 6514 523 527
8. Hsiao K. K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G., Correlative memory deficits, A elevation, and amyloid plaques in transgenic mice Science 1996 274 5284 99 102
9. Moechars D., Dewachter I., Lorent K., Revers D., Baekelandt V., Naidu A., Tesseur I., Spittaels K., Van Den Haute C., Checler F., Godaux E., Cordell B., Van Leuven F., Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain The Journal of Biological Chemistry 1999 274 10 6483 6492 (Pubitemid 29111064)
10. Chishti M. A., Yang D.-S., Janus C., Phinney A. L., Horne P., Pearson J., Strome R., Zuker N., Loukides J., French J., Turner S., Lozza G., Grilli M., Kunicki S., Morissette C., Paquette J., Gervais F., Bergeron C., Fraser P. E., Carlson G. A., St. George-Hyslop P., Westawaya D., Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695 The Journal of Biological Chemistry 2001 276 24 21562 21570
11. Sturchler-Pierrat C., Abramowski D., Duke M., Wiederhold K.-H., Mistl C., Rothacher S., Ledermann B., Brki K., Frey P., Paganetti P. A., Waridel C., Calhoun M. E., Jucker M., Probst A., Staufenbiel M., Sommer B., Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology Proceedings of the National Academy of Sciences of the United States of America 1997 94 24 13287 13292
12. Lord A., Kalimo H., Eckman C., Zhang X.-Q., Lannfelt L., Nilsson L. N. G., The Arctic Alzheimer mutation facilitates early intraneuronal A aggregation and senile plaque formation in transgenic mice Neurobiology of Aging 2006 27 1 67 77
13. Van Broeck B., Vanhoutte G., Pirici D., Van Dam D., Wils H., Cuijt I., Vennekens K., Zabielski M., Michalik A., Theuns J., De Deyn P. P., Van der Linden A., Van Broeckhoven C., Kumar-Singh S., Intraneuronal amyloid and reduced brain volume in a novel APP T714I mouse model for Alzheimer's disease Neurobiology of Aging 2008 29 2 241 252
14. Tomiyama T., Matsuyama S., Iso H., A mouse model of amyloid oligomers: their contribution to synaptic alteration, abnormal Tau phosphorylation, glial activation, and neuronal loss in vivo Journal of Neuroscience 2010 30 14 4845 4856
15. Borchelt D. R., Ratovitski T., van Lare J., Lee M. K., Gonzales V., Jenkins N. A., Copeland N. G., Price D. L., Sisodia S. S., Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins Neuron 1997 19 4 939 945
16. Blanchard V., Moussaoui S., Czech C., Touchet N., Bonici B., Planche M., Canton T., Jedidi I., Gohin M., Wirths O., Bayer T. A., Langui D., Duyckaerts C., Tremp G., Pradier L., Time sequence of maturation of dystrophic neurites associated with A deposits in APP/PS1 transgenic mice Experimental Neurology 2003 184 1 247 263
17. Richards J. G., Higgins G. A., Ouagazzal A.-M., Ozmen L., Kew J. N. C., Bohrmann B., Malherbe P., Brockhaus M., Loetscher H., Czech C., Huber G., Bluethmann H., Jacobsen H., Kemp J. A., PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation Journal of Neuroscience 2003 23 26 8989 9003
18. Casas C., Sergeant N., Itier J.-M., Blanchard V., Wirths O., Van Der Kolk N., Vingtdeux V., Van De Steeg E., Ret G., Canton T., Drobecq H., Clark A., Bonici B., Delacourte A., Benavides J., Schmitz C., Tremp G., Bayer T. A., Benoit P., Pradier L., Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated A 42 accumulation in a novel Alzheimer transgenic model American Journal of Pathology 2004 165 4 1289 1300
19. Rib E. M., Prez M., Puig B., Gich I., Lim F., Cuadrado M., Sesma T., Catena S., Snchez B., Nieto M., Gmez-Ramos P., Morn M. A., Cabodevilla F., Samaranch L., Ortiz L., Prez A., Ferrer I., Avila J., Gmez-Isla T., Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice Neurobiology of Disease 2005 20 3 814 822
20. Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y., LaFerla F. M., Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular A and synaptic dysfunction Neuron 2003 39 3 409 421
21. Grueninger F., Bohrmann B., Czech C., Ballard T. M., Frey J. R., Weidensteiner C., von Kienlin M., Ozmen L., Phosphorylation of Tau at S422 is enhanced by A in TauPS2APP triple transgenic mice Neurobiology of Disease 2009 37 2 294 306
22. Irizarry M. C., McNamara M., Fedorchak K., Hsiao K., Hyman B. T., APPSw transgenic mice develop age-related A deposits and neuropil abnormalities, but no neuronal loss in CA1 Journal of Neuropathology and Experimental Neurology 1997 56 9 965 973
23. Irizarry M. C., Soriano F., McNamara M., Page K. J., Schenk D., Games D., Hyman B. T., A deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse Journal of Neuroscience 1997 17 18 7053 7059
24. LaFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., Jay G., The Alzheimer's A peptide induces neurodegeneration and apoptotic cell death in transgenic mice Nature Genetics 1995 9 1 21 30
25. Calhoun M. E., Wiederhold K.-H., Abramowski D., Phinney A. L., Probst A., Sturchler-Pierrat C., Staufenbiel M., Sommer B., Jucker M., Neuron loss in APP transgenic mice Nature 1998 395 6704 755 756
26. Urbanc B., Cruz L., Le R., Sanders J., Hsiao Ashe K., Duff K., Stanley H. E., Irizarry M. C., Hyman B. T., Neurotoxic effects of thioflavin S-positive amyloid deposits in transgenic mice and Alzheimer's disease Proceedings of the National Academy of Sciences of the United States of America 2002 99 22 13990 13995
27. Boncristiano S., Calhoun M. E., Howard V., Bondolfi L., Kaeser S. A., Wiederhold K.-H., Staufenbiel M., Jucker M., Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice Neurobiology of Aging 2005 26 5 607 613
28. Oakley H., Cole S. L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R., Intraneuronal -amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation Journal of Neuroscience 2006 26 40 10129 10140
29. Schmitz C., Rutten B. P. F., Pielen A., Schfer S., Wirths O., Tremp G., Czech C., Blanchard V., Multhaup G., Rezaie P., Korr H., Steinbusch H. W. M., Pradier L., Bayer T. A., Hippocampal neuron loss exceeds amyloid Plaque load in a transgenic mouse model of Alzheimer's disease American Journal of Pathology 2004 164 4 1495 1502
30. Rutten B. P. F., Van der Kolk N. M., Schafer S., Van Zandvoort M. A. M. J., Bayer T. A., Steinbusch H. W. M., Schmitz C., Age-related loss of synaptophysin immunoreactive presynaptic boutons within the hippocampus of APP751SL, PS1M146L, and APP751 SL/PS1M146L transgenic mice American Journal of Pathology 2005 167 1 161 173
31. Breyhan H., Wirths O., Duan K., Marcello A., Rettig J., Bayer T. A., APP/PS1KI bigenic mice develop early synaptic deficits and hippocampus atrophy Acta Neuropathologica 2009 117 6 677 685
32. Christensen D. Z., Kraus S. L., Flohr A., Cotel M.-C., Wirths O., Bayer T. A., Transient intraneuronal A rather than extracellular plaque pathology correlates with neuron loss in the frontal cortex of APP/PS1KI mice Acta Neuropathologica 2008 116 6 647 655
33. Christensen D. Z., Bayer T. A., Wirths O., Intracellular A triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease Neurobiology of Aging 2008 31 7 1153 1163
34. Takahashi H., Brasnjevic I., Rutten B. P. F., Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer's disease Brain Structure and Function 2010 214 2-3 145 160
35. Cotel M. C., Jawhar S., Christensen D. Z., Environmental enrichment fails to rescue working memory deficits, neuron loss, and neurogenesis in APP/PS1KI mice. Neurobiology of Aging. In press
36. Faure A., Verret L., Bozon B., Impaired neurogenesis, neuronal loss, and brain functional deficits in the APPxPS1-Ki mouse model of Alzheimer's disease. Neurobiology of Aging. In press
37. Jawhar S., Trawicka A., Jenneckens C., Motor deficits, neuron loss and reduced anxiety coinciding with axonal degeneration and intraneuronal A aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiology of Aging. In press
38. Saido T. C., Iwatsubo T., Mann D. M. A., Shimada H., Ihara Y., Kawashima S., Dominant and differential deposition of distinct -amyloid peptide species, A N3(pE), in senile plaques Neuron 1995 14 2 457 466
39. Schilling S., Lauber T., Schaupp M., Manhart S., Scheel E., Bhm G., Demuth H.-U., On the seeding and oligomerization of pGlu-amyloid peptides (in vitro) Biochemistry 2006 45 41 12393 12399
40. Kuo Y.-M., Webster S., Emmerling M. R., De Lima N., Roher A. E., Irreversible dimerization/tetramerization and post-translational modifications inhibit proteolytic degradation of A peptides of Alzheimer's disease Biochimica et Biophysica Acta 1998 1406 3 291 298
41. Russo C., Violani E., Salis S., Venezia V., Dolcini V., Damonte G., Benatti U., D'Arrigo C., Patrone E., Carlo P., Schettini G., Pyroglutamate-modified amyloid -peptidesA N3(pE)strongly affect cultured neuron and astrocyte survival Journal of Neurochemistry 2002 82 6 1480 1489
42. Wirths O., Breyhan H., Cynis H., Schilling S., Demuth H.-U., Bayer T. A., Intraneuronal pyroglutamate-A 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model Acta Neuropathologica 2009 118 4 487 496
43. Tomiyama T., Nagata T., Shimada H., Teraoka R., Fukushima A., Kanemitsu H., Takuma H., Kuwano R., Imagawa M., Ataka S., Wada Y., Yoshioka E., Nishizaki T., Watanabe Y., Mori H., A new amyloid variant favoring oligomerization in Alzheimer's-type dementia Annals of Neurology 2008 63 3 377 387
44. Billings L. M., Oddo S., Green K. N., McGaugh J. L., LaFerla F. M., Intraneuronal A causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice Neuron 2005 45 5 675 688
45. Bertoni-Freddari C., Sensi S. L., Giorgetti B., Balietti M., Di Stefano G., Canzoniero L. M. T., Casoli T., Fattoretti P., Decreased presence of perforated synapses in a triple-transgenic mouse model of Alzheimer's disease Rejuvenation Research 2008 11 2 309 313
46. Grueninger F., Bohrmann B., Czech C., Ballard T. M., Frey J. R., Weidensteiner C., von Kienlin M., Ozmen L., Phosphorylation of Tau at S422 is enhanced by A in TauPS2APP triple transgenic mice Neurobiology of Disease 2010 37 2 294 306
47. Roberson E. D., Scearce-Levie K., Palop J. J., Yan F., Cheng I. H., Wu T., Gerstein H., Yu G.-Q., Mucke L., Reducing endogenous Tau ameliorates amyloid -induced deficits in an Alzheimer's disease mouse model Science 2007 316 5825 750 754